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a  b  s  t  r  a  c  t
Forming  the  ﬁrst  line  of  defence  against  virally  infected  and  malignant  cells,  natural  killer  (NK)  cells
are  critical  effector  cells  of  the  innate  immune  system.  With  age,  signiﬁcant  impairments  have  been
reported  in  the  two  main  mechanisms  by  which  NK  cells  confer  host  protection:  direct  cytotoxicity  and
the  secretion  of  immunoregulatory  cytokines  and chemokines.  In elderly  subjects,  decreased  NK  cell
activity  has been  shown  to be  associated  with  an  increased  incidence  and  severity  of viral  infection,
highlighting  the clinical  implications  that age-associated  changes  in NK  cell biology  have  on  the  health  of
older  adults.  However,  is  an increased  susceptibility  to  viral  infection  the  only  consequence  of these  age-
related  changes  in NK cell  function?  Recently,  evidence  has  emerged  that  has  shown  that  in  addition  to
eliminating  transformed  cells,  NK  cells  are  involved  in many  other  biological  processes  such as  immune
regulation,  anti-microbial  immune  responses  and  the recognition  and  elimination  of senescent  cells,
novel  functions  that involve  NK-mediated  cytotoxicity  and/or  cytokine  production.  Thus,  the  decrease
in NK cell  function  that  accompanies  physiological  ageing  is likely  to  have  wider  implications  for  the
health  of older  adults  than  originally  thought.  Here,  we  give  a detailed  description  of  the  changes  in NK
cell  biology  that accompany  human  ageing  and  propose  that certain  features  of  the  ageing process  such
as: (i) the  increased  reactivation  rates  of  latent  Mycobacterium  tuberculosis,  (ii)  the  slower  resolution  of
inﬂammatory  responses  and  (iii)  the  increased  incidence  of bacterial  and  fungal  infection  are  attributable
in  part  to  an  age-associated  decline  in  NK cell  function.© 2013 Elsevier B.V. All rights reserved.
ontents
1. Introduction  . .  . . . .  . .  .  . . .  .  . . .  .  . . .  .  . .  .  . . .  . . . . . . .  .  . . . .  . . . .  . . . .  . . . . . . . . . .  . .  .  .  . .  .  . . .  . . .  . . . . . .  . . . . . . .  . . . . . . .  .  . . . . . . .  .  . . .  .  . . .  .  . . . . .  . . .  . .  . . . . . . . . . .  . .  .  . . .  . .  .  .  . 1070
1.1. NK  cell  function.  .  . . .  . . .  .  . . .  . . . .  .  . . .  .  . . .  . . . .  . . .  . . . .  . . . . .  . . . . . .  . . . .  . . .  .  . . . .  .  . . .  . . . .  .  . . . . . .  .  . .  . . . .  .  . . . . . .  . .  .  . . . .  . . .  .  . .  .  . . . .  .  .  .  .  . . . . . . .  . . .  . .  .  . .  . .  .1070
1.1.1. NKCC  . . .  .  . . .  . . .  .  . . .  .  . . .  .  . . .  . . . .  . . . .  . . . .  . . . . . . .  . . .  . . .  . . . .  . .  .  . .  . . . . .  . . .  . . .  . . .  . . .  .  . . . . .  . . .  . . . . .  . . . . .  . . . . . . . . .  .  .  . . .  . . . . . . .  . .  .  .  .  .  .  . . . . .  .  .  . 1070
1.1.2.  Cytokine  and chemokine  production. . .  . . . . . .  .  . . .  . . .  . . .  .  . . . . . .  .  . . . .  . . . . . . . . . . .  . . . . . . .  .  . . . .  . .  .  . .  . . .  .  .  . . . .  . . .  . .  .  . . . .  .  . . . .  .  .  . .  . . .  .  .  .  . .1071
1.2.  Age-associated  changes  in NK cell  biology. . .  . . . .  . . .  . . . . . . .  .  . . . .  . .  .  . . . . . .  . . . . . . . .  . . . . . . . . . . . . . .  .  . . .  . . . .  .  . . .  . . . . .  . .  . . .  .  .  . . . . . . . . .  .  . . .  . .  .  . . . . .  .1071
1.2.1.  Effect  of  age  on NK  cell  frequency  and  the  composition  of the circulating  NK  pool.  . .  .  . . . . . . .  . . .  . . . . .  .  .  . . .  . . . . . .  .  . . .  .  .  .  . . . . . . .  .  . .1071
1.2.2.  Effect  of  age  on NK cell  phenotype  . .  .  .  . . .  . . .  .  . .  .  . . .  .  . . . . . . . . .  . . .  . . .  . .  . . . . .  . . .  . . . . .  . . . .  .  . . . . . . . .  .  .  .  . .  .  . . . .  .  .  .  . . . .  . . .  .  .  .  . . . .  .  . . . . . . . . 1072
1.2.3.  Effect  of  age  on NKCC  and  ADCC  . . . . . . .  . . .  .  . . . . . .  .  . . . .  .  . . .  . . . .  . . . . . . . .  .  . . . .  . . .  . . . . . . .  . . . .  .  . . .  .  .  . .  . . . .  .  . . . .  .  .  .  . .  . . . . . . . . . .  .  . .  .  . .  .  . .  . 1072
1.2.4.  Effect  of  age  on NK cell  migration  .  .  . . .  .  . . .  . . . .  .  . . .  . . . . .  . .  .  . . . . . .  . . .  . . . .  .  . . . . . .  . . . . .  . . .  . . . .  . . .  . . . . . . .  . . . .  . . .  .  . . . . .  .  . .  .  . .  . . . .  . . . . . .  . . 1073
1.2.5.  Effect  of  age  on the  response  to and  production  of cytokines  and  chemokines  . .  . . . . .  .  . .  . . . .  . . .  .  . . . . . . . .  .  .  .  . . . .  .  . . . . .  .  .  .  .  . .  . .  .  .  .  . 10731.3.  NK cell  immunesenescence  and  its impact  upon  healthy  ageing  . .
1.3.1. Accumulation  of senescent  cells  . .  . . . .  . . .  . . . . . . .  .  .  . . .  .  . .  . .
1.3.2.  Impaired  crosstalk  between  the  innate  and adaptive  arm
Abbreviations: ADCC, antibody dependent cell cytotoxicity; Apaf-1, apoptosis-activa
ytomegalovirus; DC, dendritic cell; DLN, draining lymph node; FasL, Fas ligand; FADD
Nase; IFN-, interferon gamma; IL-8, interleukin 8; KIR, killer cell immunoglobulin like
rotein; MIP-1,  macrophage inﬂammatory protein-1-alpha; NCR, natural cytotoxicity re
DPribose polymerase; PBLs, peripheral blood lymphocytes; PMA, phorbol 12-myristate 1
NF-,  tumour necrosis factor alpha; Th-1, T helper 1 cell; TRAIL, tumor necrosis factor re
∗ Corresponding author. Tel.: +44 121 371 3264; fax: +44 121 414 3599.
E-mail addresses: J.Hazeldine@bham.ac.uk (J. Hazeldine), J.M.Lord@bham.ac.uk (J.M. L
568-1637/$ – see front matter ©  2013 Elsevier B.V. All rights reserved.
ttp://dx.doi.org/10.1016/j.arr.2013.04.003 .  . .  . . . . . . .  .  . . . . . .  . . . . . . .  .  .  .  . .  . . .  .  . . . .  . .  .  . . .  .  . .  . . . . . . . . .  .  . .  .  .  .  .  . . . . . . .  . . . . 1073
 . .  . . .  . . . . . . . . .  . . . .  . . . . . . . .  . .  .  . . .  . . . .  . . . . . . .  .  . . . .  . . . . . . . . .  . .  .  .  . .  . . .  . . .  . . . . 1074
s  of  the  immune  system  . . . . . .  . .  . . .  .  .  . . . .  .  . . . .  .  . . .  . . .  .  . . . . . . . . .  .  . .  .  . . .  . 1074
ting factor 1; BID, BH3-interacting domain; CAD, caspase-activated DNase; CMV,
, Fas-associated protein with death domain; iCAD, inhibitor of caspase-activated
 receptor; MHC, major histocompatibility complex; MIC, MHC  class I-chain-related
ceptor; NK cell, natural killer cell; NKCC, natural killer cell cytotoxicity; PARP, poly
3-acetate; TB, Mycobacterium tuberculosis; tBID, truncated BH3-interacting domain;
lated apoptotic-inducing ligand.
ord).
1070 J. Hazeldine, J.M. Lord / Ageing Research Reviews 12 (2013) 1069– 1078
1.3.3.  Delayed  resolution  of inﬂammatory  responses  . . . . . .  .  . . . . . .  .  . . . . . . .  . . . . .  . . .  . . . . .  . . . .  . . . . . .  .  . .  .  . . . .  . . . . .  .  .  . . . .  . . . . .  .  . . .  .  .  .  . . . . . .  .  . . 1075
1.3.4.  Increased  reactivation  rates  of  M. tuberculosis  (TB)  .  . . . . . .  .  . .  . . . .  . . . . . . .  . . .  . . .  . .  . . . . . . . . . . . . .  .  . . .  .  . . . . . .  .  . . . . . .  .  . .  .  . . . . . .  .  . .  .  . .  . . .  . 1075
1.3.5.  Reduced  anti-microbial  immunity  . . .  . . . .  . . .  .  . . . . . .  .  .  . . .  .  .  .  .  . . .  . .  .  . . . . . .  . . . . .  . . .  . . . .  . . .  . .  . . .  . . . .  .  . . . . . . . . . . . . . . . .  .  .  .  .  . . . .  .  . . . . . . . .  . 1075
1.4.  Conclusions  .  . . .  .  .  . .  .  .  . .  .  . . . .  . . .  . . .  . . .  .  . . .  .  . . .  .  .  . .  .  . . .  .  . . . . . .  .  . . . .  .  . . . .  .  .  .  . . . .  .  . . . . . . .  .  .  . .  . . .  . . .  . . . . .  . . . .  . . . .  . . . . . . . .  . . . . . . . . .  . . . .  .  .  .  .  . .  . . . . . . . 1075
Acknowledgment  . . .  . .  .  . . .  .  . . .  .  . .  .  .  . .  . . . .  . . .  .  . . . . . . .  .  . . .  .  .  . .  . . . . . .  . . . . .  . . . . . . .  .  . .  . . . .  .  . . . . . . . .  . . . . .  .  . .  . . . . . . . .  . .  .  . . .  .  .  . . . .  . . .  .  .  . . . . . . . . . .  .  . .  .  . .  . . . .  . . 1075
 . . . . .  .
1
r
i
i
c
t
d
n
e
s
p
s
p
e
c
i
w
t
a
2
h
m
s
m
c
o
(
V
f
i
c
t
r
i
f
r
(
c
o
c
1
a
t
t
t
(
k
C
h
mReferences .  .  . . . .  . . . .  . . .  .  . . .  .  . . .  .  . . . . . .  . . .  .  . . .  .  . . .  .  .  . .  .  .  . .  . . . .  .  . . . . . .  .  .
. Introduction
Comprising 10–15% of the circulating lymphocyte pool, natu-
al killer (NK) cells are large granular lymphocytes of the innate
mmune system renowned for their ability to recognise and elim-
nate virally infected, stressed and malignant cells. In humans, NK
ells, whose defensive strategies include direct cytotoxicity and
he secretion of immunoregulatory cytokines and chemokines, are
eﬁned by a CD3− CD56+ surface phenotype. However, they are
ot a homogenous population, as based on the differential surface
xpression of CD56, NK cells are categorised into two major sub-
ets: CD56DIM and CD56BRIGHT, which differ both in their receptor
roﬁle and function (Cooper et al., 2001a).
Physiological ageing is associated with changes in the compo-
ition, phenotype and function of the circulating NK cell pool, a
henomenon referred to as NK cell immunesenescence (Solana
t al., 1999; Solana and Mariani, 2000; Tarazona et al., 2012). As NK
ells represent the ﬁrst line of defence against virally infected cells,
mmunogerontological studies often introduce or conclude their
ork by proposing that NK cell immunesenescence contributes to
he higher incidence of viral infection that is reported by older
dults (Mariani et al., 1996; Rukavina et al., 1998; Mariani et al.,
002a; Hayhoe et al., 2010). However, over the past decade, data
as emerged demonstrating that NK cell function extends beyond
erely the recognition and elimination of transformed cells, with
tudies being published implicating a role for NK cells in: (i) anti-
icrobial defence (Small et al., 2008; Schmidt et al., 2011), (ii) the
learance of senescent cells (Sagiv et al., 2012), (iii) the resolution
f inﬂammation (Thoren et al., 2012; Waggoner et al., 2012) and
iv) modulating adaptive immunity (Martin-Fontecha et al., 2004;
itale et al., 2005). Thus, NK cell immunesenescence may  have more
ar reaching effects upon the health of older adults than simply
ncreasing their susceptibility to viral infection.
Here, after discussing NK cell function and the changes in NK
ell biology that occur with age, we review data which suggest
hat in addition to the previously described association between
educed NKCC in older adults and an increased incidence of viral
nfection (Levy et al., 1991; Ogata et al., 1997, 2001) that other
eatures of the ageing process may  be attributable in part to age-
elated alterations in NK function and phenotype. These include:
i) the increased reactivation rates of latent Mycobacterium tuber-
ulosis (TB), (ii) reduced vaccination efﬁcacy, (iii) slower resolution
f inﬂammatory responses and (iv) the accumulation of senescent
ells.
.1. NK cell function
NK cell cytotoxicity (NKCC) and the secretion of cytokines
nd chemokines are the two main mechanisms NK cells use
o eliminate transformed and virus-infected cells. Induction of
hese defensive strategies is governed by signals transmitted
hrough germline-encoded activatory and inhibitory receptors
Lanier, 1998). Inhibitory receptors, which include members of the
iller-cell immunoglobulin-like receptor (KIR) superfamily and the
-type lectin family member CD94/NKG2A, recognise self major
istocompatibility complex (MHC) class I molecules and trans-
it  inhibitory signals through an immunoreceptor tyrosine-based . . . .  . . .  . . . . .  .  . . .  .  . . . . .  . .  . . . . . . .  . . . . .  . . .  .  . . .  . . .  .  .  . . . . .  .  .  .  .  .  . . . . . . . . . .  .  . .  .  . 1075
inhibitory motif within their cytoplasmic domain (Lanier, 1998;
Pegram et al., 2011). Examples of activatory receptors are the natu-
ral cytotoxicity receptors (NCR) NKp30, NKp44 and NKp46, which
recognise viral haemagglutinin (Arnon et al., 2001; Mandelboim
et al., 2001) and bacterial surface proteins (Esin et al., 2008), the Fc
receptor CD16, which allows NK cells to perform antibody depend-
ent cell cytotoxicity (ADCC) and the C-type lectin family member
NKG2D, whose ligands include the stress-inducible glycoproteins
MHC class I-chain-related protein A (MICA) and MICB (Bauer et al.,
1999).
1.1.1. NKCC
NK cells directly eliminate transformed cells through two
contact-dependent mechanisms: granule exocytosis and death
receptor ligation (Fig. 1; Smyth et al., 2005). Of these, granule exo-
cytosis, which is performed predominantly by CD56DIM NK cells, is
the main pathway by which NK cells confer host protection (Sayers
et al., 1998; Smyth et al., 1999), and is characterised by the secretion
of cytotoxic proteins into the immunological synapse that forms
between an NK cell and its target (Fig. 1A; Smyth et al., 2005). Of
the proteins released, it is the membrane-disrupting protein per-
forin and a family of serine proteases termed granzymes that are
the critical effector molecules.
Current work suggests that after binding to phospholipid
components of the target cell membrane, perforin undergoes poly-
merisation, triggering a membrane-repair response within the
target cell that results in the co-endocytosis of membrane-bound
perforin and granzymes (Thiery et al., 2010, 2011). Once inside the
target cell, perforin has been shown to induce endosomal lysis,
leading to the release of granzymes into the cytosol (Thiery et al.,
2010, 2011). Human NK cells express ﬁve granzymes, namely A,
B, H, K and M (Smyth et al., 2005). Of these, granzyme B has been
the subject of considerable interest. As an aspartase, granzyme B
cleaves proteins after aspartic acid residues. Consequently, several
members of the caspase family are directly activated by granzyme
B, including caspase 3 (Goping et al., 2003). This effector cas-
pase induces apoptosis by several mechanisms, which include:
(1) activating the endonuclease caspase-activated DNase (CAD)
by degrading its inhibitory binding partner, inhibitor of caspase-
activated DNase (iCAD) and (2) degrading proteins involved in DNA
repair (e.g. poly ADPribose polymerase (PARP)) (Fig. 1A; Heusel
et al., 1994; Darmon et al., 1995; Chinnaiyan et al., 1996; Taylor
et al., 2008). As well as direct activation, granzyme B activates cas-
pases 3 and 7 indirectly by driving mitochondrial permeabilisation
(Fig. 1A). This occurs via granzyme B-mediated cleavage of the BH-
3 family protein BH3-interacting domain (BID) death agonist into
its truncated form (tBID). Once formed, tBID translocates to the
mitochondria where it induces permeabilisation, leading to the
release of the pro-apoptotic protein cytochrome c into the cyto-
sol (Fig. 1A; Alimonti et al., 2001). Here, cytochrome c associates
with ATP, apoptosis-activating factor 1 (Apaf-1) and pro-caspase 9,
forming a structure referred to as the apoptosome (Bao and Kumar,
2007). Formation of this complex results in the activation of cas-
pase 9, which subsequently mediates cell death by cleaving and
activating caspases 3 and 7 (Fig. 1A; Bao and Kumar, 2007). In addi-
tion to mediating caspase-dependent apoptosis, granzyme B can
trigger target cell death in a caspase-independent manner. This is
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Fig. 1. Mechanisms of natural killer cell cytotoxicity (NKCC). NK cells directly elim-
inate transformed cells through one of two  contact-dependent mechanisms. (A)
The  granule exocytosis pathway. Following target cell recognition and activation, NK
cells secrete an array of lytic effector molecules into the immunological synapse.
These molecules include the pore-forming protein perforin and a family of serine
proteases termed granzymes. Binding of these proteins to the target cell surface
triggers their uptake into endosomes, which are subsequently lysed by perforin,
resulting in the release of apoptosis-inducing granzymes into the cytoplasm (Thiery
et  al., 2010, 2011). Shown in the ﬁgure are the 3 pathways by which granzyme B
mediates target cell death. (1) As an aspase, granzyme B cleaves and directly acti-
vates effector caspases (e.g. caspases 3 and 7), which subsequently induce target cell
apoptosis by degrading proteins involved in DNA repair (e.g. poly ADP ribose poly-
merase (PARP)) and activating the endonuclease caspase-activated DNase (CAD)
by  degrading its inhibitory binding partner, inhibitor of caspase-activated DNase
(iCAD). (2) As well as activating caspases 3 and 7 directly, granzyme B can indirectly
activate these proteases by cleaving the BH-3 family protein BH3-interacting domain
(BID) death agonist into its truncated form (tBID). tBID translocates to the mitochon-
dria, where it induces permeabilisation, leading to the release of cytochrome c. The
presence of cytochrome c along with other pro-apoptotic proteins in the target cell
cytosol results in the activation of the initiator caspase, caspase 9, which mediates
cell  death by cleaving and activating caspases 3 and 7. (3) In addition to inducing
caspase-dependent target cell death, granzyme B can trigger caspase-independent
cell  death by directly cleaving proteins involved in DNA repair and maintenance.
These proteins include PARP, inhibitor of caspase-activated DNase (iCAD) and the
nuclear protein lamin B. (B) Death receptor ligation. Activated NK cells express on
their surface Fas ligand (FASL) and TNF-related apoptotic inducing ligand (TRAIL),
which bind their cognate receptors, Fas and TRAIL-R respectively on the target cell
surface. Ligand binding leads to receptor oligomerisation and the recruitment of the
cytosolic adaptor protein Fas-associated protein with death domain (FADD) along
with the initiator caspases, pro-caspase 8 and 10 to the target cell membrane. For-
mation of this complex, referred to as the death-induced signalling complex (DISC),
triggers the activation of caspases 8 and 10, which subsequently induce apoptosis
by  activating caspase 3 either directly via cleavage or indirectly by generating tBID,
which leads to cell death by driving mitochondrial permeabilisation, cytochrome c
release and caspase 3 activation.h Reviews 12 (2013) 1069– 1078 1071
achieved through the direct cleavage of proteins involved in DNA
repair (e.g. PARP) and maintenance (e.g. lamin B) (Fig. 1A; Froelich
et al., 1996; Thomas et al., 2000; Zhang et al., 2001).
Alongside granule exocytosis, NK cells directly eliminate trans-
formed cells through death receptor engagement (Fig. 1B). In
response to cytokine stimulation (Medvedev et al., 1997; Sato et al.,
2001) or following ligation of activatory receptors (Wallin et al.,
2003; Chua et al., 2004), NK cells express on their surface Fas ligand
(FasL) and TNF-related apoptosis-inducing ligand (TRAIL), which
bind to Fas and TRAIL receptor respectively on the target cell sur-
face. This interaction results in the formation within the target cell
of a death induced signalling complex consisting of the adaptor
molecule Fas-associated protein with death domain (FADD) and
pro-caspases 8 and 10 (Bao and Kumar, 2007). Formation of this
complex leads to the activation of both caspases, which promote
target cell death by activating caspase 3 either directly via cleavage
or indirectly by cleaving BID into tBID, which induces mitochondrial
permeabilisation and the release of cytochrome c (Fig. 1B; Lavrik
et al., 2005).
1.1.2. Cytokine and chemokine production
NK cells activated by cytokine stimulation (Krishnaraj and
Bhooma, 1996; Mariani et al., 2001, 2002b) or target cell
challenge (Fauriat et al., 2010; De et al., 2011) secrete a mul-
titude of immunoregulatory cytokines and chemokines such as
tumour necrosis factor alpha (TNF-), interferon gamma (IFN-),
interleukin (IL)-8 and macrophage inﬂammatory protein-1-alpha
(MIP-1). Via the production of these soluble mediators, NK cells
can amplify on-going innate immune responses by enhancing the
activity of bystander cells and can also inﬂuence the early phases
of an adaptive immune response by promoting dendritic cell (DC)
maturation and T cell differentiation. For instance, through the
secretion of IFN- and/or TNF-, NK cells have been shown to not
only enhance the antigen presenting capacity and cytotoxic activity
of macrophages but also to drive the maturation of immature DC’s
(Bancroft et al., 1989; Trinchieri, 1995; Vitale et al., 2005). Further-
more, in an elegant in vivo study, Martin-Fontecha and colleagues
demonstrated that after migrating to draining lymph nodes (DLN),
NK cells helped drive T helper-1 (Th-1) cell polarisation by secreting
IFN- (Martin-Fontecha et al., 2004).
1.2. Age-associated changes in NK cell biology
Numerous studies have investigated the effect of physiological
ageing on the biology of human NK cells. In this section, we  review
the ﬁndings of those that have examined its impact on the com-
position and phenotype of the circulating NK cell pool and NK cell
function.
1.2.1. Effect of age on NK cell frequency and the composition of
the circulating NK pool
A signiﬁcant increase in the percentage and/or absolute number
of CD3− CD56+ NK cells is the general ﬁnding reported by studies
that have investigated the effect of age on NK cell frequency (Lutz
et al., 2005; Di et al., 1999; Le Garff-Tavernier et al., 2010; Lutz et al.,
2011; Hazeldine et al., 2012). As physiological ageing is accompa-
nied by a reduction in NK cell production and proliferation (Zhang
et al., 2007), this age-related increase in NK cell number may be
the result of an accumulation of long-lived NK cells in older adults
(Zhang et al., 2007).
Immunogerontological studies that have examined the effect
of age on the composition of the circulating NK cell pool have
found a greater proportion of CD57+ NK cells in older adults (Lutz
et al., 2005; Simpson et al., 2008; Le Garff-Tavernier et al., 2010;
Hazeldine et al., 2012). As a marker of NK maturity, an increased
percentage of CD57+ cells suggests a shift towards a more mature
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irculating NK pool occurs with age. With regards to NK cell sub-
ets, studies have shown that whilst the proportions and/or number
f CD56DIM NK cells increase with age (Almeida-Oliveira et al.,
011; Lutz et al., 2011; Hazeldine et al., 2012) older adults possess
igniﬁcantly fewer CD56BRIGHT NK cells (Le Garff-Tavernier et al.,
010; Almeida-Oliveira et al., 2011; Lutz et al., 2011; Hazeldine
t al., 2012), resulting in a marked age-related increase in the
D56DIM:CD56BRIGHT ratio (Krishnaraj, 1997; Hayhoe et al., 2010;
azeldine et al., 2012). In the only study to have investigated the
ffect of age on the frequency of CD56− NK cells, a subset that
xhibits defective natural and ADCC but comparable chemokine
ecretion when compared to CD56DIM NK cells (Hu et al., 1995;
lter et al., 2005; Mavilio et al., 2005), no age-related difference
as reported (Lutz et al., 2011).
.2.2. Effect of age on NK cell phenotype
The effect of age on the expression of certain NK cell activatory
eceptors is controversial. Whereas some groups have reported an
ge-related decline in the percentage of NK cells expressing NKp30
r NKp46 (Almeida-Oliveira et al., 2011; Hazeldine et al., 2012;
arazona et al., 2012), which in the case of NKp30 is accompanied by
 reduction in its surface density (Tarazona et al., 2012), others have
emonstrated no effect for age on the proportions of NK cells bear-
ng these receptors (Le Garff-Tavernier et al., 2010). More consistent
ndings have however been reported for NKG2D and CD16 whose
evels are maintained with age (Lutz et al., 2005; Hayhoe et al.,
010; Le Garff-Tavernier et al., 2010; Hazeldine et al., 2012). With
egards to inhibitory receptors, KIR expression has been reported to
e increased or unaltered with age (Lutz et al., 2005, 2011; Almeida-
liveira et al., 2011). In contrast, marked age-associated reductions
n KLRG-1 and NKG2A have been documented (Lutz et al., 2005,
011; Hayhoe et al., 2010), as has a decline in CD94, the binding
artner of NKG2A (Lutz et al., 2005; Hayhoe et al., 2010; Almeida-
liveira et al., 2011; Hazeldine et al., 2012).
Recently, Bigley et al. (2012) demonstrated that infection with
he latent herpes virus cytomegalovirus (CMV) has a marked impact
n the surface phenotype of NK cells. The group, who  used blood
amples obtained solely from young donors, found that when com-
ared to their seronegative counterparts, CMV+ individuals had a
ower frequency of KLRG1+/CD57− NK cells and a higher proportion
f KLRG1−/CD57+ NK cells (Bigley et al., 2012), which is reminis-
ent of the circulating NK pool of older adults (Lutz et al., 2005; Le
arff-Tavernier et al., 2010; Hayhoe et al., 2010; Hazeldine et al.,
012). Consequently, Bigley et al. (2012) have proposed that the
hanges in NK cell phenotype that accompany human ageing may
ot be due to the ageing process per se but a greater prevalence of
MV among older individuals.
Thus, a decline in the expression of KLRG1, NKG2A and its bind-
ng partner CD94 with age has been reported by several groups.
ssessing NK cell phenotype in older individuals who  are CMV
eronegative versus seropositive would help to provide a possible
xplanation for some of these changes notably in KLRG1.
.2.3. Effect of age on NKCC and ADCC
All studies published to date that have examined the effect of age
n NKCC have focused exclusively upon target cell death induced
y the granule exocytosis pathway, with nothing known regarding
he impact of age on death receptor mediated killing. However,
n spite of a focus on the granule exocytosis pathway, consider-
ble differences in study outcome have been described, with some
roups reporting a signiﬁcant age-related decline in NKCC (Facchini
t al., 1987; Miyaji et al., 1997; Di et al., 1999; Hazeldine et al.,
012) and others demonstrating the lytic activity of NK cells to be
ncreased (Onsrud, 1981; Krishnaraj and Blandford, 1987; Kutza
nd Murasko, 1994) or unchanged (Facchini et al., 1987; Nagel
t al., 1981; Almeida-Oliveira et al., 2011) with age. Inter-studyh Reviews 12 (2013) 1069– 1078
differences in subject inclusion criteria and protocol design may
account for these discordant ﬁndings. For example, whereas
some groups have performed NKCC assays with PBMCs (Facchini
et al., 1987; Nagel et al., 1981; Kutza and Murasko, 1994;
Almeida-Oliveira et al., 2011), others have used peripheral blood
lymphocytes (Onsrud, 1981; Di et al., 1999) or puriﬁed NK cells
(Facchini et al., 1987; Miyaji et al., 1997) as their effector popu-
lation. Furthermore, the studies differ in the length of time they
co-cultured NK cells with their targets before assessing NKCC, the
signiﬁcance of which was illustrated in the work of Rukavina et al.
(1998), who found NKCC exhibited an age-related decline in short-
term (2 h) assays, but that after prolonged co-culture (18 h) the lytic
activity of NK cells from aged donors was comparable to that of their
younger counterparts.
One aspect of protocol design that was consistent throughout
all of the aforementioned studies was the use of the MHC  class I
deﬁcient K562 cell line as the target population. Although the cell
line of choice for in vitro work, it is unlikely that the surface of
every transformed cell encountered by NK cells in vivo is devoid
of ligands that deliver inhibitory signals. For instance, an immune
evasion strategy deployed by human CMV  is to up-regulate the
expression of the non-classical HLA molecule HLA-E, a ligand for
the inhibitory receptor CD94/NKG2A, on the surface of infected
host cells (Tomasec et al., 2000). Interestingly, it has been shown
that signals transmitted to NK cells through the activatory recep-
tor NKG2D can override those delivered by inhibitory receptors,
thereby allowing NK cells to eliminate MHC  class I positive targets
(Bauer et al., 1999; Cerwenka et al., 2001). Whether physiologi-
cal ageing has a detrimental effect upon the ability of NK cells to
eliminate target cells that simultaneously deliver inhibitory and
activatory signals is unknown. Performing experiments that com-
pare the lytic activity of NK cells from young and old subjects
towards target cells with varying surface expression of inhibitory
receptor ligands would help address this issue.
Despite the conﬂicting observations described above, the gen-
eral consensus within the NK cell ﬁeld is that at the single cell
level, NKCC is reduced with age (Facchini et al., 1987; Mariani
et al., 1990; Almeida-Oliveira et al., 2011; Hazeldine et al., 2012).
Indeed, an age-related increase in the proportions and/or abso-
lute numbers of circulating NK cells was  reported by many of the
studies that found NKCC to be comparable between young and old
donors when PBMCs were used as effector cells (Facchini et al.,
1987; Mariani et al., 1990; Almeida-Oliveira et al., 2011), whereas
an age-associated decrease in lytic activity has been reported by
the majority of groups that have used puriﬁed NK cells at ﬁxed con-
centrations in their cytolytic assays (Facchini et al., 1987; Mariani
et al., 1990; Miyaji et al., 1997). Thus, the aforementioned increase
in the circulating frequency of CD56DIM NK cells that occurs with
age (Almeida-Oliveira et al., 2011; Lutz et al., 2011; Hazeldine et al.,
2012)) may  represent a compensatory mechanism that counter-
acts the age-associated decrease in NKCC at the single cell level
(Mocchegiani and Malavolta, 2004).
NK cells from older adults recognise and bind to tumour tar-
gets as effectively as those from younger subjects, suggesting the
age-related impairment in NKCC is the result of a post-binding
defect (Facchini et al., 1987; Ligthart et al., 1989; Vitale et al.,
1992; Mariani et al., 1998). Reduced expression of perforin and
the aforementioned age-associated alterations in the expression
of NK cell activatory (e.g. NKp30 and NKp46) and inhibitory (e.g.
KIR) receptors are two mechanisms that have been proposed to
underlie the age-related decline in NKCC (Rukavina et al., 1998;
Almeida-Oliveira et al., 2011). However, not all groups agree with
these proposals, with some studies showing no effect for age on
perforin expression (Mariani et al., 1996; Hazeldine et al., 2012)
and others reporting no difference in NKCC despite marked alter-
ations in receptor expression with age (Almeida-Oliveira et al.,
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011). Recently, we showed for the ﬁrst time that following tar-
et cell recognition, NK cells from older adults release less perforin
nto the immunological synapse when compared to NK cells from
heir younger counterparts, a defect we attributed to an age-related
mpairment in the polarisation of lytic granules to the NK target
ell interface (Hazeldine et al., 2012). Underlying this impairment
ppears to be aberrant intracellular signalling proximal to the
K cell membrane as when NK cells are treated with phorbol
2-myristate 13-acetate (PMA) and ionomycin, two agents that
ypass cell surface receptors to induce NK cell degranulation, no
ge-associated difference in perforin release is found (J. Hazel-
ine, unpublished observations). Supporting this idea, Mariani
t al. (1998) have previously shown that following target cell
timulation, NK cells from older adults generate signiﬁcantly less
f the second messenger inositol 1,4,5-triphosphate, the result
f an age-related delay in phosphatidylinositol 4,5-bisphosphate
ydrolysis. Thus, we propose that reduced perforin release, due
o compromised cell signalling involved in perforin granule local-
sation to the immune synapse, underlies the age-related decline
n NKCC.
ADCC appears to be unaffected by the ageing process. Studies
ave shown no difference in CD16 expression with age (Hayhoe
t al., 2010; Hazeldine et al., 2012) or in the ability of NK cells from
ld donors to lyse antibody-coated target cells (Edwards and Avis,
979; Fernandes and Gupta, 1981; Lutz et al., 2005). However, as
he NK cell pool of older adults is dominated by CD57+ NK cells
Lutz et al., 2005; Simpson et al., 2008; Le Garff-Tavernier et al.,
010; Hazeldine et al., 2012), which exhibit potent ADCC (Lopez-
erges et al., 2010), it may  be that similar to natural cytotoxicity,
DCC is also impaired at the single cell level with age.
.2.4. Effect of age on NK cell migration
A crucial step in NK cell-mediated defence is their migration
hrough tissue to the site of inﬂammation, where upon arrival they
ecognise, bind and eliminate their targets. Results of two  recent
urine studies suggest that NK cell migration is impaired with age.
n a model of inﬂuenza infection, Beli et al. (2001) found signiﬁ-
antly lower numbers of NK cells in the lungs and spleen of aged
ice at both day two and day four post infection when compared to
he corresponding samples from young mice. This observation was
n agreement with earlier work that had reported an age-associated
ecline in the recruitment of NK cells to draining lymph nodes
ollowing viral challenge (Fang et al., 2010). In this latter study,
efective NK cell migration was partly attributed to signiﬁcantly
educed expression of L-selectin, a molecule critical for lymphocyte
oming to lymph nodes (Fang et al., 2010).
To our knowledge, no study has been performed that has directly
ssessed the impact of human ageing on NK cell migration. How-
ver, some groups have examined its effect on the expression of
urface receptors known to be involved in this process. No age-
elated differences have been observed in the expression of the
dhesion receptor CD2 (Hayhoe et al., 2010) or the chemokine
eceptors CCR3 or CCR5 (Mariani et al., 2002a, 2002b). In contrast,
he density of CXCR1, a receptor for the chemokine IL-8, has been
hown to be markedly lower on the surface of NK cells from older
dults (Mariani et al., 2002a), although no effect for age was  found
hen the frequency of CXCR1+ NK cells was measured (Mariani
t al., 2001, 2002a).
Further research is clearly required in order to gain a greater
nderstanding of the impact ageing has on NK cell migration. How-
ver, based on existing data, it appears that this function of NK
ells is reduced with age, which when combined with the afore-
entioned impairment in NKCC, would be expected to compromise
heir ability to eliminate cellular targets in vivo.h Reviews 12 (2013) 1069– 1078 1073
1.2.5. Effect of age on the response to and production of cytokines
and chemokines
Cytokine stimulation markedly enhances NKCC. In vitro this is
assessed by the ability of cytokine-activated NK cells to induce
lysis of the NK cell resistant Daudi cell line. Cytokine-activated
NK cells from older adults exhibit greater cytotoxicity against
Daudi target cells than their untreated counterparts indicating
that NK cells from older adults are responsive to cytokine treat-
ment (Kutza and Murasko, 1996; Krishnaraj, 1997; Mariani et al.,
2001). However, whether the level of cytotoxicity achieved is
different to that of cytokine-activated NK cells from younger
adults is currently unclear (Kutza and Murasko, 1994, 1996;
Krishnaraj and Bhooma, 1996; Krishnaraj, 1997; Mariani et al.,
2001).
NK cells isolated from old subjects respond to cytokine stim-
ulation by up-regulating their production of IFN-, MIP-1 and
IL-8 (Krishnaraj and Bhooma, 1996; Krishnaraj, 1997; Mariani
et al., 2001, 2002b). However, the levels generated are signiﬁ-
cantly lower than those produced by NK cells from younger subjects
(Krishnaraj and Bhooma, 1996; Mariani et al., 2001, 2002a, 2002b).
As it is the CD56BRIGHT NK cell subset that primarily responds to
cytokine challenge (Cooper et al., 2001b; Fehniger et al., 2003;
Ferlazzo et al., 2004; Anfossi et al., 2006), one explanation for
this impaired response could be the aforementioned age-related
decline in CD56BRIGHT NK cells (Le Garff-Tavernier et al., 2010;
Almeida-Oliveira et al., 2011; Lutz et al., 2011; Hazeldine et al.,
2012). Recently, target cells have been shown to trigger cytokine
and chemokine production by NK cells (Fauriat et al., 2010; De et al.,
2011). In a small pilot study, we have found the amount of IFN-,
MIP-1 and IL-8 but not TNF- produced by target cell-stimulated
NK cells from older adults is signiﬁcantly lower than the levels
secreted by NK cells from younger subjects (J. Hazeldine, unpub-
lished observations). These results along with the aforementioned
cytokine data suggest the immunoregulatory capacity of NK cells
is reduced with age.
1.3. NK cell immunesenescence and its impact upon healthy
ageing
Given the signiﬁcant role of NK cells in anti-viral defence (Biron
et al., 1989; Etzioni et al., 2005; Eidenschenk et al., 2006), stud-
ies that have examined the impact of NK  cell immunesencene
on the health of older adults have to date focused primarily on
their response to viral challenge, reporting that decreased NKCC in
these individuals is associated with a past history of severe infec-
tion, an increased incidence of infectious disease and a reduced
probability of survival following infection (Levy et al., 1991; Ogata
et al., 1997, 2001). However, in light of recent work that sug-
gests the role of NK cells extends beyond anti-viral immunity into
such areas as the resolution of inﬂammation (Thoren et al., 2012;
Waggoner et al., 2012) and the recognition and elimination of
senescent cells (Sagiv et al., 2012), it is likely that NK cell immune-
senescence has wider implications on the health of older adults
than ﬁrst thought. Indeed, it has been proposed that in addition to
increasing the susceptibility of older adults to viral infection (Levy
et al., 1991; Ogata et al., 1997, 2001), age-associated changes in
NK cell function may  be responsible in part for the increased fre-
quency of senescent cells found in aged tissue (Sagiv et al., 2012)
and the poorer adaptive immune responses elicited by aged sub-
jects (Tarazona et al., 2012). In this section, as well as discussing
these ideas, we propose NK cell immunesenescence may  underlie
other features of the ageing process such as the increased reactiva-
tion rates of M. tuberculosis, the slower resolution of inﬂammatory
responses and the increased incidence of bacterial and fungal infec-
tion (Fig. 2).
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Fig. 2. Features of the ageing process proposed to result in part from age-associated changes in NK cell biology. It is hypothesised that alongside the previously described
association between decreased NKCC and an increased susceptibility to viral infection in older subjects (Levy et al., 1991; Ogata et al., 1997, 2001) that the age-related
reduction in perforin-mediated cytotoxicity and cytokine/chemokine production along with changes in NK cell surface phenotype have additional consequences for the
health  of older adults. These are proposed to include: (1) the accumulation of senescent cells and the subsequent development of such age-related pathologies as sarcopenia
and  cardiovascular disease (Sagiv et al., 2012), (2) slower resolution of inﬂammatory responses and increased immune-mediated tissue damage due to impaired NK-mediated
elimination of neutrophils, (3) increased reactivation rates of latent Mycobacterium tuberculosis (TB) due to impaired production of IFN- by NK cells and reduced recognition
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.3.1. Accumulation of senescent cells
A feature of physiological ageing is the appearance of senescent
ells. These cells, which have been detected in skin (Dimri et al.,
995), bone (Price et al., 2002) and endothelium (Minamino et al.,
002) from older adults, reside in a state of irreversible cell cycle
rrest, yet remain metabolically active, secreting an array of growth
actors, pro-inﬂammatory cytokines and proteases. Recently, evi-
ence has emerged that suggests that by compromising tissue
omeostasis and function, senescent cell accumulation contributes
o the development of several age-associated pathologies such as
arcopenia and cataracts (Baker et al., 2011).
The immune system is involved in the recognition and elim-
nation of senescent cells. In different experimental settings,
acrophages, neutrophils, NK cells and T cells have all been
mplicated in the clearance of senescent cells (Xue et al., 2007;
rizhanovsky et al., 2008; Kang et al., 2011). In a recent article,
agiv and co-workers demonstrated that NK-mediated elimination
f senescent cells occurs exclusively through the granule exocytosis
athway (Sagiv et al., 2012), a ﬁnding that led the group to specu-
ate that an age-related decline in perforin-mediated NKCC may  be
esponsible in part for the increased frequency of senescent cells
ound in aged tissue (Dimri et al., 1995; Minamino et al., 2002; Price
t al., 2002; Sagiv et al., 2012). Recently, we have shown that when
ompared to those isolated from younger subjects, NK cells from
lder adults release signiﬁcantly less perforin into the immunolog-
cal synapse that is formed following target cell contact (Hazeldineer vaccination responses as a result of impaired NK cell-dendritic cell (DC) cross-talk
et al., 2012), a defect, which based on the ﬁndings of Sagiv et al.
(2012) would be expected to hamper the ability of NK cells from
older adults to remove senescent cells.
1.3.2. Impaired crosstalk between the innate and adaptive arms
of the immune system
It is now recognised that the innate and adaptive arms of the
immune system undergo considerable cross-talk and reciprocal
interaction. Via direct cytotoxicity and cytokine production, NK
cells ﬁnd themselves at the interface of this relationship by inﬂu-
encing DC maturation and T cell differentiation.
NK cell-DC cross-talk has two outcomes for DCs. Following
direct contact and the recognition of an unknown ligand on the
DC surface by the NCR NKp30, activated NK cells have been shown
to: (i) directly lyse iDCs, which may  be a means by which NK cells
limit iDC activation at sites of antigenic challenge (Ferlazzo et al.,
2002; Moretta, 2002), and (ii) secrete IFN- and TNF-, thereby
promoting DC maturation (Vitale et al., 2005). As well as inﬂuenc-
ing a T cell response indirectly by modulating the maturity status
of DCs, NK cells, in times of infection have been shown to migrate
to T cell zones of DLN, where via IFN- secretion, they drive Th-1
cell polarisation (Martin-Fontecha et al., 2004).With age, expression of NKp30 on the NK cell surface is reduced
(Tarazona et al., 2012; J. Hazeldine, unpublished observations), as
is the level of granule-mediated cytotoxicity and the amount of
IFN- produced by stimulated NK cells from older adults (Facchini
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t al., 1987; Krishnaraj and Bhooma, 1996; Miyaji et al., 1997;
i et al., 1999; Hazeldine et al., 2012; J. Hazeldine, unpublished
bservations). Thus, as well as adversely affecting the immedi-
te response to transformed cells, NK cell immunesenescence may
ave a negative impact upon the development of an adaptive
mmune response. On this note, Tarazona et al. (2012) have pro-
osed that the reduced expression of NKp30 they observed on the
urface of aged NK cells would have a detrimental effect upon NK-
C crosstalk, leading to a less effective adaptive immune response
gainst virus-infected and malignant cells (Tarazona et al., 2012).
oreover, it is reasonable to think that as a result of reduced IFN-
ecretion, NK cells from older adults would be less efﬁcient at driv-
ng DC maturation and T cell polarisation. Interestingly, work by
ysliwska et al. (2004) has shown that the generation of protective
nti-hemagglutinin titres and the production of Th-1 cell cytokines
ollowing inﬂuenza vaccination is markedly lower in older adults
ith low NK activity when compared to those with high NK activ-
ty, which was associated with a greater incidence of respiratory
ract infection in the former group (Mysliwska et al., 2004). This
nadequate response to vaccination may  be related in some part
o the aforementioned changes in NK biology adversely affecting
he ability of these cells to inﬂuence the early phases of adaptive
mmunity.
.3.3. Delayed resolution of inﬂammatory responses
An unexpected role for NK cells in immune regulation has
ecently emerged. In murine models of viral infection, NK cells
ave been shown to lyse DCs as well as CD4+ and CD8+ T cells in a
erforin-dependent manner (Andrews et al., 2010; Waggoner et al.,
012; Lang et al., 2012), whilst in vitro, NK cells induce neutrophil
poptosis by death receptor ligation, which requires recognition of
n as of yet unidentiﬁed ligand on the neutrophil surface by the
CR NKp46 (Thoren et al., 2012).
In aged individuals, the frequency of NKp46+ NK cells is reduced
Almeida-Oliveira et al., 2011; Hazeldine et al., 2012), which we
xpect would lead to reduced neutrophil recognition by NK cells.
hether NK cell lysis induced by death receptor ligation is altered
ith age is currently unknown. However, reduced interaction
etween NK cells and neutrophils as a result of a decline in NKp46
xpression would in our opinion result in reduced rates of NK-
ediated neutrophil apoptosis, consequences of which could be
he slower resolution of inﬂammatory responses that has been
eported in older adults (Boyd and Orihuela, 2011), and the onset
f neutrophil necrosis, which would lead to local tissue damage.
n this note, the aforementioned lysis of CD4+ T cells by NK cells
as been proposed in a model of viral infection to promote host
urvival by preventing immune-mediated pathology (Waggoner
t al., 2012). Thus, the decrease in perforin-mediated NKCC that
e have shown occurs with age (Hazeldine et al., 2012) suggests
hat the immune regulatory function of NK cells may  be impaired.
his may  contribute to the increased severity of infection in older
dults, along with the longer resolution phase and recovery time
ollowing infection.
.3.4. Increased reactivation rates of M.  tuberculosis (TB)
Based on in vitro studies that have shown NK cells lyse TB-
nfected monocytes and macrophages, and generate signiﬁcant
mounts of IFN- when exposed to these infected phagocytes
Vankayalapati et al., 2002, 2005), NK cells are thought to
e involved in the immune response against this intracellular
acterium. With age, reactivation rates of latent TB increase
Horsburgh et al., 2010), suggesting that the immune response
owards this pathogen may  be altered in older adults. Since an age-
elated decrease in the frequency of NK cells that express NKp46,
n activating receptor involved in the recognition of TB-infected
onocytes and macrophages (Vankayalapati et al., 2002, 2005),h Reviews 12 (2013) 1069– 1078 1075
has been reported (Almeida-Oliveira et al., 2011; Hazeldine et al.,
2012), along with a reduction in IFN- secretion by NK cells from
older adults (Krishnaraj and Bhooma, 1996; J. Hazeldine, unpub-
lished observations), then a weakened NK response may  contribute
to this greater rate of TB reactivation in older adults (Horsburgh
et al., 2010).
1.3.5. Reduced anti-microbial immunity
Although renowned for their anti-viral properties, the role of
NK cells in host defence is not limited to just protecting against
infection with these intracellular pathogens. Through perforin-
mediated cytotoxicity and the secretion of IFN-, NK cells have
been implicated in the immune response against bacteria and fungi,
either by directly targeting these pathogens for lysis or by enhanc-
ing the activity of bystander immune cells (Scott et al., 2003; Ma
et al., 2004; Sporri et al., 2006; Schmidt et al., 2011).
Compared to younger subjects, older adults report an increased
incidence of bacterial and fungal infection (Marston et al., 1997;
Kauffman, 2001; Janssens and Krause, 2004). Although an age-
associated decline in the function of neutrophils, which represent
the ﬁrst-line of defence against these pathogens, has been pro-
posed as the major factor underlying this increased rate of infection
(Lord et al., 2001; Wessels et al., 2010), NK cell immunesenescence
may  also be a contributory factor. The decrease in NKCC mediated
by the granule exocytosis pathway that occurs with age would
reduce the anti-fungal activity of NK cells (Facchini et al., 1987;
Miyaji et al., 1997; Di et al., 1999; Hazeldine et al., 2012), whereas
the age-related decline in IFN- secretion (Krishnaraj and Bhooma,
1996; J. Hazeldine, unpublished observations) would have a nega-
tive impact on bacterial clearance, as through the secretion of this
cytokine, NK cells have been shown to enhance the anti-bacterial
activity of tissue-resident macrophages (Scott et al., 2003). Thus,
reduced NK cell function may  compromise bacterial as well as viral
immunity.
1.4. Conclusions
Recent studies in the ﬁeld of NK cell research have shown the
function of these innate lymphocytes extends beyond their well-
documented role in anti-viral and tumour immunity into such areas
as immune regulation, the initiation of adaptive immune responses,
anti-microbial immunity and the clearance of senescent cells. Thus,
besides the much publicised increase in viral infection rates, several
features of the ageing process such as the reduced efﬁcacy of vac-
cination, the appearance of senescent cells and the higher rates of
fungal infection may  be attributable in part to the decline in NK cell
function that accompanies human ageing. If true, then developing
strategies to prevent, delay or reverse NK cell immunesenescence
may  be one way by which to improve the health of older adults.
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